| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.036 | 0.8 |